What is a trial in the follow up stage?
Trials in this stage are closed to new patients but are not yet complete.
During this stage patients may still be participating in the trial; they may be having routine tests and doctor visits, and their condition may continue to be carefully monitored. The research team will also be gathering and reviewing the data and findings.
Depending on the nature of the trials, some trials can be in the follow up stage for many years.
When the follow up stage is complete, the trial’s results can be published.
Each trial listed here is linked to the world’s most comprehensive listing of trials, clinicaltrials.gov, where you can find out more information about each trial.
| Code | Study Name | Disease Area | Study Type |
| CTRIAL-IE 24-12 | ANTHOS ANT 008 – Magnolia | Basket | Industry |
| CTRIAL-IE 21-07 | DESTINY DS8201-A-U306 | Gastrointestinal | Industry |
| CTRIAL-IE 16-41 | NBL Lines | Paediatric | Collaborative |
| CTRIAL-IE 18-36 | LOXO-TRK-15003 | Paediatric | Industry |
| CTRIAL-IE 16-82 | MyeChild (AML) | Paediatric | Collaborative |
| CTRIAL 21-37 | MK-6482-022 | Genitourinary | Industry |
| CTRIAL-IE 21-06 | KRYSTAL-10 | Gastrointestinal | Industry |
| CTRIAL 21-18 | MK6482-012 | Genitourinary | Industry |
| CTRIAL 21-17 | MK6482-011 | Genitourinary | Industry |
| CTRIAL 22-10 | Bioprotect PMCF study (CLP-10441) | Genitourinary | Industry |
| CTRIAL-IE-21-13 | KRYSTAL-12 | Lung | Industry |
| CTRIAL-IE-21-12 | CA224-104 (RELATIVITY) | Lung | Industry |
| CTRIAL-IE-18-49 | AbbVie M14-239 | Lung | Industry |
| CTRIAL-IE 21-34 | LEAP-015 (MK-7902-015) | Gastrointestinal | Industry |
| CTRIAL-IE 19-32 | DASL HiCaP | Genitourinary | Collaborative |
| CTRIAL-IE 20-02 | TERAVOLT | Lung | Collaborative |
| CTRIAL-IE 22-06 | MK7684A-008 | Lung | Industry |
| CTRIAL-IE 11-34 | TIGER | Genitourinary | Collaborative |
| CTRIAL-IE 21-40 | TROPIC | Genitourinary | Industry |
| CTRIAL-IE 21-39 | BMS CA209-67T | Genitourinary | Industry |
| CTRIAL-IE 15-46 | PACE-C | Genitourinary | Collaborative |
| CTRIAL-IE 21-25 | CANOPY-A | Lung | Collaborative |
| CTRIAL-IE 17-37 | MK3475-671 | Lung | Industry |
| CTRIAL-IE 18-27 | PORTEC-4a | Gynaecology | Collaborative |
| CTRIAL-IE 18-02 | NRG GU005 | Genitourinary | Collaborative |
| CTRIAL-IE 18-30 | KEYNOTE-859 (MK3475-859) | Gastrointestinal | Industry |
| CTRIAL-IE 19-23 | MK3475-966-00 | Gastrointestinal | Industry |
| CTRIAL-IE 18-21 | MK3475-811 (KEYNOTE 811) | Gastrointestinal | Industry |
| CTRIAL-IE 18-43 | MK7902-002/E7080-G000-311/LEAP-002 | Gastrointestinal | Industry |
| CTRIAL-IE 17-07 | CHECKMATE 744 | Lymphoma & blood cancers | Industry |
| CTRIAL-IE 18-48 | CALLS (INCB 84344-401) | Lymphoma & blood cancers | Industry |
| CTRIAL-IE 15-41 | ROAM | Central Nervous System | Collaborative |
| CTRIAL-IE20-05 | COSMIC-312 | Gastrointestinal | Industry |
| CTRIAL-IE16-08 | Millennium Pevonedistat P2001 | Lymphoma & blood cancers | Industry |
| CTRIAL-IE17-34 | MK3475-495 | Lung | Industry |
| CTRIAL-IE18-31 | MK3475-564 | Genitourinary | Industry |
| CTRIAL-IE18-22 | CHIMERIX ADAPT | Paediatric | Industry |
| CTRIAL-IE18-14 | Regeneron 2810 ONC 16113/EMPOWER | Lung | Industry |
| CTRIAL-IE17-40 | MK3475-698 | Genitourinary | Industry |
| CTRIAL-IE17-09 | MK3475-598 | Lung | Industry |
| CTRIAL-IE17-05 | MK3475-361 | Genitourinary | Industry |
| CTRIAL-IE17-03 | CO39303 (Roche) | Genitourinary | Industry |
| CTRIAL-IE16-63 | Roche MO29518 PDL1 | Basket | Industry |
| CTRIAL-IE16-62 | Roche MO29983 SAUL | Genitourinary | Industry |
| CTRIAL-IE16-45 | FACT | Paediatric | Collaborative |
| CTRIAL-IE16-39 | NBL LTI Study | Paediatric | Collaborative |
| CTRIAL-IE16-27 | MK3475-426/KEYNOTE-426 | Genitourinary | Industry |
| CTRIAL-IE16-25 | Roche MO29438/Performance status | Lung | Industry |
| CTRIAL-IE15-40 | EORTC 1416 PEARLS/MK-3475-091/KEYNOTE 091 | Lung | Industry |
| CTRIAL-IE15-28 | INTELLANCE 1 M13-813 | Central Nervous System | Industry |
| CTRIAL-IE15-25 | Bayer 16349-CHRONOS-1 | Lymphoma & blood cancers | Industry |
| CTRIAL-IE14-12 | MDV3100-12 | Breast | Industry |
| CTRIAL-IE14-08 | MONALEESA-2 | Breast | Collaborative |
| CTRIAL-IE14-07 | ANZUP ENZARAD | Genitourinary | Collaborative |
| CTRIAL-IE13-15 | Novartis CLDK378A2303 (LDK378) / ASCEND 5 | Lung | Industry |
| CTRIAL-IE13-14 | Novartis CLDK378A2301 (LDK378) / ASCEND 4 | Lung | Industry |
| CTRIAL-IE13-11 | MDV3100-11 | Breast | Industry |
| CTRIAL-IE15-03 | NSABP B-51 | Breast | Collaborative |
| CTRIAL-IE15-34 | Recurrence Score | Breast | In-House |
| CTRIAL-IE15-02 | PantHER | Breast | In-House |
| CTRIAL-IE17-33 | VIOLETTE | Breast | Industry |
| CTRIAL-IE19-08 | SOLSTICE | Gastrointestinal | Industry |
| CTRIAL-IE16-39 | NBL LTI Study | Paediatric | Collaborative |
| CTRIAL-IE18-35 | ENGOT-cx8 | Gynaecology | Collaborative |
| CTRIAL-IE18-26 | ATHENA | Gynaecology | Collaborative |
| CTRIAL-IE08-13 | Serum Protein Markers for Glioma | CNS | In-House |
| CTRIAL-IE15-34 | Ovarian Reserve | Breast | In-House |
| CTRIAL-IE19-10 | RAD1901-308 /EMERALD | Breast | Industry |
| CTRIAL-IE18-01 | The tBRCA study | Gynaecology | In-House |
| CTRIAL-IE18-43 | MK7902-002 | Gastrointestinal | Industry |
| CTRIAL-IE18-31 | KEYNOTE-564 | Genitourinary | Industry |
| CTRIAL-IE14-04 | iPROSPECT | Genitourinary | In-House |
| CTRIAL-IE16-70 | CA209-274 | Genitourinary | Industry |
| CTRIAL-IE16-69 | E7080-G000-307 | Genitourinary | Industry |
| CTRIAL-IE15-36 | Onconova 04-30/INSPIRE | Lymphoma & blood cancers | Industry |
| CTRIAL-IE11-29 | ICON8B | Gynaecology | Collaborative |
| CTRIAL-IE17-06 | CHRONOS-4 | Lymphoma & blood cancers | Industry |
| CTRIAL-IE15-38 | CHRONOS-3 | Lymphoma & blood cancers | Industry |
| CTRIAL-IE19-09 | KEYNOTE-775 | Gynaecology | Industry |
| CTRIAL-IE13-23 | Neo Adjuvant Abiraterone Prostate | Genitourinary | In-House |
| CTRIAL-IE10-11 | Circulating miRNA | Breast | In-House |
| CTRIAL-IE14-02 | SHAPE study | Gynaecology | Collaborative |
| CTRIAL-IE16-20 | POSITIVE | Breast | Collaborative |
| CTRIAL-IE16-60 | CLL13 | Lymphoma & blood cancers | Collaborative |
| CTRIAL-IE06-02 | SOFT | Breast | IBCSG |
| CTRIAL-IE10-06 | BIG 3-07/TROG 07.01 (DCIS) | Breast | Collaborative |
| CTRIAL-IE06-31 | TAILORx | Breast | Collaborative |
| CTRIAL-IE06-32 | NSABP B-42 | Breast | Collaborative |
| CTRIAL-IE08-01 | CADY | Breast | In-House |
| CTRIAL-IE11-10 | TH vs THL | Breast | In-House |
| CTRIAL-IE11-24 | NSABP B-47 | Breast | Collaborative |
| CTRIAL-IE12-01 | SWOG S1007 | Breast | Collaborative |
| CTRIAL-IE12-02 | E3A06 | Myeloma | Collaborative |
| CTRIAL-IE12-40 | EORTC 10085 | Breast | Collaborative |
| CTRIAL-IE12-43 | TRIO 022/PALOMA | Breast | Collaborative |
| CTRIAL-IE12-45 | SNAP | Breast | Collaborative |
| CTRIAL-IE14-01 | EMBRACA | Breast | Industry / Collaborative |
| CTRIAL-IE15-33 | Keynote-119 | Breast | Industry |
| CTRIAL-IE15-29 | INTELLANCE 2 M14-483 | Central Nervous System | Industry |
| CTRIAL-IE15-37 | CHRONOS 2 | Lymphoma & blood cancers | Industry |
| CTRIAL-IE08-17 | IMRT Prostate | Genitourinary | In-House |
| CTRIAL-IE11-04 | ECOG 2809 | Genitourinary | Collaborative |
| CTRIAL-IE12-22 | BMS CA209-025/CheckMate 025 | Genitourinary | Industry |
| CTRIAL-IE12-29 | IMPACT | Genitourinary | Collaborative |
| CTRIAL-IE13-21 | Radium-223 & Enzalutamide mCRPC | Genitourinary | In-House |
| CTRIAL-IE14-06 | ANZUP ENZAMET | Genitourinary | Collaborative |
| CTRIAL-IE15-31 | MK3475-045/KEYNOTE-045 | Genitourinary | Industry |
| CTRIAL-IE15-32 | MK3475-052/KEYNOTE-052 | Genitourinary | Industry |
| CTRIAL-IE15-45 | BMS CA209-214/CheckMate 214 | Genitourinary | Industry |
| CTRIAL-IE15-13 | MK-3475-040/KEYNOTE-040 | Head & neck | Industry |
| CTRIAL-IE16-11 | NRG-HN002 | Head & neck | Collaborative |
| CTRIAL-IE06-36 | ECOG 15-05 | Lung | Industry |
| CTRIAL-IE14-13 | MK-3475-024/KEYNOTE-024 | Lung | Industry |
| CTRIAL-IE16-16 | MK-3475-189/KEYNOTE-189 | Lung | Industry |
| CTRIAL-IE16-17 | BMS CA 209-171 | Lung | Industry |
| CTRIAL-IE16-24 | Roche IMpower 132 | Lung | Industry |
| CTRIAL-IE15-10 | OPTIMISMM | Lymphoma & blood cancers | Industry |
| CTRIAL-IE14-24 | BMS CA209-238/CheckMate 238 | Melanoma | Industry |
| CTRIAL-IE13-02 | BMS CA209-067/CheckMate-067 | Melanoma | Industry |
| CTRIAL-IE16-02 | CyBorD-DARA | Myeloma | Collaborative |
| CTRIAL-IE16-78 | AbbVie M14-031 | Lymphoma & blood cancers | Industry |
| CTRIAL-IE16-79 | AbbVie M15-550 (VENICE I) | Lymphoma & blood cancers | Industry |
| CTRIAL-IE15-27 | BMS CA 209-227 | Lung | Industry |
| CTRIAL-IE14-11 | PENELOPE-B | Breast | Collaborative |
| CTRIAL-IE16-12 | SWOG 1404 | Melanoma | Industry |
| CTRIAL-IE16-54 | BMS CA209-714 | Head & Neck | Industry |
| CTRIAL-IE16-04 | PRIMA | Gynaecology | Industry |
| CTRIAL-IE10-15 | Exosomal and FE Predictive Biomarkers for HER2 Therapies | Breast | In-House |
| CTRIAL-IE14-22 | Radium-223 vs Placebo study | Breast | Industry |
| CTRIAL-IE12-30 | TailorX Tissue Bank | Breast | In-House |
| CTRIAL-IE17-08 | KEYNOTE-522 | Breast | Industry |
| CTRIAL-IE15-05 | 10-028 Oligo-Recurrent Stereotactic Radiotherapy | Lung | Collaborative |
| CTRIAL-IE12-53 | SPLENDOUR | Lung | Collaborative |
| CTRIAL-IE16-18 | BMS CA209-451/CheckMate 451 | Lung | Industry |
| CTRIAL-IE17-10 | MK3475-604 | Lung | Industry |
| CTRIAL-IE17-36 | MK3475-654 | Lung | Industry |
| CTRIAL-IE17-35 | MK3475-715 | Lung | Industry |
| CTRIAL-IE15-17 | PALLAS | Breast | Collaborative |
| CTRIAL-IE15-16 | GEICAM/2014-12 (FLIPPER) | Breast | Collaborative |
| CTRIAL-IE15-49 | NeoTRIP | Breast | Collaborative |
| CTRIAL-IE13-09 | PEACE-1 | Genitourinary | Collaborative |
| CTRIAL-IE13-22 | SYS-ACT | Melanoma | In-House |
| CTRIAL-IE16-47 | EpSSG/RMS 2005 | Paediatric | Collaborative |
| CTRIAL-IE16-38 | NBL—HR-NBL-1.7/SIOPEN | Paediatric | Collaborative |
| CTRIAL-IE16-33 | UKALL2011 | Paediatric | Collaborative |
| CTRIAL-IE16-32 | AALL1131 | Paediatric | Collaborative |
| CTRIAL-IE16-31 | AALL0932 | Paediatric | Collaborative |
| CTRIAL-IE16-30 | AALL08B1 | Paediatric | Collaborative |
| CTRIAL-IE15-19 | CARD | Genitourinary | Industry |
| CTRIAL-IE17-22 | Javelin Head & Neck 100 | Head & Neck | Industry |
| CTRIAL-IE17-20 | BMS CA209-651 | Head & Neck | Industry |
| CTRIAL-IE17-23 | BMS CA209-9LA | Lung | Industry |
| CTRIAL-IE16-61 | ETOP 10-16 BOOSTER | Lung | Collaborative |
| CTRIAL-IE16-15 | EMR 100070-005/Javelin Lung 100 | Lung | Industry |
| CTRIAL-IE16-10 | Keynote 185 | Multiple Myeloma | Industry |